In summary, logistic regression and decision tree models constructed using age, lymphadenopathy, pleural thickening, and brain metastasis show promise for noninvasive prediction of EGFR 19Del and 21L858R mutation subtypes in lung adenocarcinoma. This evidence concerns the gene EGFR and lung adenocarcinoma.